Actions of general anaesthetics and arachidonic acid pathway inhibitors on K+ currents activated by volatile anaesthetics and FMRFamide in molluscan neurones

British Journal of Pharmacology

Volumn 125, Issue 2, 1998, Pages 309-318

  Lopes, C M B ^a,b   Franks, N P ^a   Lieb, W R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohols; Arachidonic acid; Cytochrome P450; FMRFamide; General anaesthesia; Potassium channels; Volatile anaesthetics

Indexed keywords

4 AMINOPYRIDINE; ALCOHOL; ANESTHETIC AGENT; ARACHIDONIC ACID; ARISTOLOCHIC ACID; CHLOROFORM; CLOTRIMAZOLE; CYTOCHROME P450; ECONAZOLE; ENFLURANE; HALOTHANE; HEXANOL; INDOMETACIN; INHALATION ANESTHETIC AGENT; ISOFLURANE; LAURYL ALCOHOL; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE; PHOSPHOLIPASE A2 INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; PROSTAGLANDIN SYNTHASE INHIBITOR; SEVOFLURANE; TETRYLAMMONIUM;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; MOLLUSC; NERVE CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; VOLTAGE CLAMP;

ALCOHOLS; ANESTHETICS, GENERAL; ANESTHETICS, INHALATION; ANIMALS; ARACHIDONIC ACIDS; CYCLOOXYGENASE INHIBITORS; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FMRFAMIDE; HALOTHANE; LIPOXYGENASE INHIBITORS; MOLLUSCA; NEURONS; POTASSIUM CHANNELS;

EID: 0031668491     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702069     Document Type: Article

References (41)

1. ALIFIMOFF, J.K., FIRESTONE, L.L. & MILLER, K.W. (1989). Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the anaesthetic site. Br. J. Pharmacol., 96, 9-16.
2. ALLOTT, P.R., STEWARD, A., FLOOK, V. & MAPLESON, W.W. (1973). Variation with temperature of the solubilities of inhaled anaesthetics in water, oil and biological media. Br. J. Anaesth., 45, 294-300.
3. + channels by cytochrome P-450 inhibitors. J. Biol. Chem., 267, 11789-11793.
4. BAHLS, F.H., RICHMOND, J.E., SMITH, W.L. & HAYDON, P.G. (1992). A lipoxygenase pathway of arachidonic acid metabolism mediates FMRFamide activation of a potassium current in an identified neuron of Helisoma. Neurosci. Letts., 138, 165-168.
5. + channels in Aplysia. Neuron, 3, 497-505.
6. + channels. Nature, 325, 153-156.
7. BELL, G.H. (1973). Solubilities of normal aliphatic acids, alcohols and alkanes in water. Chem. Phys. Lipids, 10, 1-10.
8. + channels by a 12-lipoxygenase metabolite of arachidonic acid. Nature, 342, 553-555.
9. CRITZ, S.D., BAXTER, D.A. & BYRNE, J.H. (1991). Modulatory effects of serotonin, FMRFamide, and myomodulin on the duration of action potentials, excitability, and membrane currents in tail sensory neurons of Aplysia. J. Neurophysiol., 66, 1912-1926.
10. CURRY, S., MOSS, G.W.J., DICKINSON, R., LIEB, W.R. & FRANKS, N.P. (1991). Probing the molecular dimensions of general anaesthetic target sites in tadpoles (Xenopus laevis) and model systems using cycloalcohols. Br. J. Pharmacol. 102, 167-173.
11. 2 in the action of general anesthetics. Am. J. Physiol., 270, C636-C644.
12. DICKINSON, R., FRANKS, N.P. & LIEB, W.R. (1994). Can the stereoselective effects of the anesthetic isoflurane be accounted for by lipid solubility? Biophys. J., 66, 2019-2023.
13. ESTABROOK, R.W. (1996). The remarkable P450s: a historical overview of these versatile hemeprotein catalysts. FASEB J., 10, 202-204.
14. + channel. EMBO J., 15, 6854-6862.
15. FIRESTONE, L.L., MILLER, J.C. & MILLER, K.W. (1986). Tables of physical and pharmacological properties of anesthetics. In Molecular and Cellular Mechanisms of Anesthetics. ed. Roth, S.H. & Miller, K.W. pp. 455-470. New York: Plenum.
16. FRANKS, N.P. & LIEB, W.R. (1985). Mapping of general anaesthetic target sites provides a molecular basis for cutoff effects. Nature, 316, 349-351.
17. + current. Nature, 333, 662-664.
18. FRANKS, N.P. & LIEB, W.R. (1991a). Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels. Science, 254, 427-430.
19. FRANKS, N.P. & LIEB, W.R. (1991b). Selective effects of volatile general anesthetics on identified neurons. Annals N.Y. Acad. Sci., 625, 54-70.
20. FRANKS, N.P. & LIEB, W.R. (1993). Selective actions of volatile general anaesthetics at molecular and cellular levels. Br. J. Anaesth., 71, 65-76.
21. FRANKS, N.P. & LIEB, W.R. (1996). Temperature dependence of the potency of volatile general anesthetics. Implications for in vitro experiments. Anesthesiology, 84, 716-720.
22. GIRDLESTONE, D., CRUICKSHANK, S.G.H & WINLOW, W. (1989). The actions of three volatile general anaesthetics on withdrawal responses of the pond snail Lymnaea stagnalis (L.). Comp. Biochem. Physiol., 92C, 39-43.
23. GOLDSTEIN, S.A.N., PRICE, L.A., ROSENTHAL, D.N. & PAUSCH, M.H. (1996). ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A., 93, 13256-13261.
24. + channel. Anesthesiology. 88, 1076-1084.
25. A receptor. Br. J. Pharmacol., 112, 906-910.
26. HILLE, B. (1992). Ionic Channels of Excitable Membranes. 2nd edition. Sunderland, Massachusetts: Simmer Associates Inc.
27. 3 receptors in N1E-115 neuroblastoma cells. Br. J. Pharmacol., 117, 1507-1515.
28. LABELLA, F.S. & QUEEN, G. (1995). Subanesthetic concentrations of drugs inhibit cytochrome P450-mediated metabolism of aniline. Eur. J. Pharmacol., 293, 231-235.
29. + channel. FEBS Letts., 402, 28-32.
30. MOMBOULI, J.-V. & VANHOUTTE, P.M. (1997). Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmucol. Sci., 18, 252-256.
31. NEWDLEMAN, P., TURK, J., JAKSCHIK, B.A., MORRISON, A.R. & LEFKOWITH, J.B. (1986). Arachidonic acid metabolism. Ann. Rev. Biochem., 55, 69-102.
32. PIOMELLI, D. (1994). Eicosanoids in synaptic transmission. Crit. Rev. Neurobiol., 8, 65-83.
33. PIOMELLI, D. & GREENGARD, P. (1990). Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol. Sci., 11, 367-373.
34. PIOMELLI, D., VOLTERRA, A., DALE, N., SIEGELBAUM, S.A., KANDEL, E.R., SCHWARTZ, J.H. & BEHARDETTI, H. (1987). Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature, 328, 38-43.
35. RAVENTÓS, J. (1956). The action of Fluothane-a new volatile anaesthetic. Br. J. Pharmacol. Chemother., 11, 394-410.
36. 19F NMR spectroscopy. J. Pharmac. Biomed. Anal., 10, 1-7.
37. + channels in Aplysia sensory neurones. Nature, 299, 413-417.
38. VAN DYKE, R.A. & RIKANS, L.E. (1970). Effect of the volatile anesthetics on aniline hydroxylase and aminopyrine demethylase. Biochem. Pharmacol., 19, 1501-1502.
39. + channel by cyclic AMP and arachidonic acid metabolites in Aplysia sensory neurons. Proc. Natl. Acad. Sci. U.S.A., 85, 7810-7814.
40. WATTS, M.T., ESCARZAGA, M. & WILLIAMS, C.H. (1992). Gas Chromatographic headspace analysis of sevoflurane in blood. J. Chromatography, 577, 289-298.
41. WINEGAR, B.D., OWEN, D.F., YOST, C.S., KORSAYETH, J.R. & MAYHRI, E. (1996). Volatile general anesthetics produce hyperpolarization of Aplysia neurons by activation of a discrete population of baseline potassium channels. Anesthesiology, 85, 889-900.